Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Clinical and psychometric assessment scores were better, and improvements determined by clinicians were greater in supplement users than in the placebo groups
Those who may qualify for GLP-1 receptor agonistssuch as Ozempic, Wegovy, Mounjaro and Zepboundtypically include individuals with a Body Mass Index (BMI) of 30 or higher, or 27 and above with weight-related conditions such as hypertension, high cholesterol or sleep apnea
If currently on Mounjaro, discuss transition options with your prescriber before making changes
These warnings were originally included as a precaution, partly based on concerns seen with older weight loss medications
CrossRef Molecular Landscape and Diagnostic Model of MASH: Transcriptomic, Proteomic, Metabolomic, and Lipidomic Perspectives Yilong Chen, Shuixiu Bian, Jiamei Le Genes .2025
There are also theoretical concerns regarding heart rate elevation , as observed with other agents in this class
US$ 28.46
US$ 29.72
US$ 27.47
US$ 24.29
